Skip to main content
logo
Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan flag Japan · Delayed Price · Currency is JPY
10,455
+160 (1.55%)
At close: Feb 27, 2026

Chugai Pharmaceutical Revenue

In the year 2025, Chugai Pharmaceutical had annual revenue of 1.26T JPY with 7.46% growth. Chugai Pharmaceutical had revenue of 343.50B in the quarter ending December 31, 2025, with 13.71% growth.

Revenue
1.26T
Revenue Growth
+7.46%
P/S Ratio
13.68
Revenue / Employee
250.29M
Employees
7,872
Market Cap
17.21T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.26T87.33B7.46%
Dec 31, 20241.17T59.24B5.33%
Dec 31, 20231.11T-148.58B-11.79%
Dec 31, 20221.26T260.19B26.02%
Dec 31, 2021999.76B212.81B27.04%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Otsuka Holdings2.47T
Astellas Pharma2.06T
Daiichi Sankyo Company2.05T
Ono Pharmaceutical509.35B
Kyowa Kirin496.83B
Santen Pharmaceutical287.99B
JCR Pharmaceuticals37.55B
Perseus Proteomics140.41M
Revenue Rankings

Chugai Pharmaceutical News

More News